1. Home
  2. IART vs FLGT Comparison

IART vs FLGT Comparison

Compare IART & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$11.13

Market Cap

867.7M

Sector

Health Care

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$26.03

Market Cap

867.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IART
FLGT
Founded
1989
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
867.7M
867.4M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
IART
FLGT
Price
$11.13
$26.03
Analyst Decision
Hold
Buy
Analyst Count
7
3
Target Price
$15.00
$28.33
AVG Volume (30 Days)
697.1K
195.6K
Earning Date
02-24-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,642,966,000.00
$315,549,000.00
Revenue This Year
$3.26
$16.84
Revenue Next Year
$2.71
$9.74
P/E Ratio
N/A
N/A
Revenue Growth
4.99
13.61
52 Week Low
$10.70
$14.57
52 Week High
$27.13
$31.04

Technical Indicators

Market Signals
Indicator
IART
FLGT
Relative Strength Index (RSI) 37.37 36.98
Support Level $10.70 $25.85
Resistance Level $12.08 $28.19
Average True Range (ATR) 0.55 0.70
MACD -0.14 -0.23
Stochastic Oscillator 15.72 4.19

Price Performance

Historical Comparison
IART
FLGT

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Share on Social Networks: